Abstract P022: The Geographic Variations In Hypertension Medication Adherence
Abstract
Objective: Hypertension (HTN) affects 47% of adults in the United States (US). Medication adherence is difficult to achieve due to its benign course. This study aims to characterize the difference in HTN medication adherence between major regions of the US and the incongruity between urban and rural areas.
Methods: This is a cross-sectional study consisting of 11,494 persons, representing over 71 million adults in the US, with a diagnosis of HTN. Data was obtained from the National Health Interview Survey in 2020. Variables include HTN medication adherence, access to regular care, household region, and urban-rural classification as defined by the National Center for Health Statistics. Chi-square test and logistic regression was used to compare the study groups.
Results: HTN medication adherence was 75.6% in large urban (LU), 81.5% in large fringe urban (FU), 81.1% in medium urban (MU), and 83.3% in nonmetro (NM) areas [p < 0.001]. Using urban as the baseline comparison for a logistic regression model, a statistically significant difference was observed between LU and each individual group [p < 0.001] . This association remained significant when adjusting for covariates of BMI, marital status, insurance status, race, and age [p < 0.001]. Also, patients in LU were least likely to have a regular healthcare provider at 94.7% followed by 95.9% in FU, and 97.0% in MU and NM [p < 0.01].
Adherence across U.S. regions, defined as Northeast, South, Midwest, and West was statistically significant [p <0.01]. On logistic regression, West had a significantly lower adherence rate at 76.6% when compared to other regions [OR 0.69; 95% CI 0.56, 0.85; p < 0.05]. The odds increased further when adjusting for covariates of BMI, marital status, insurance status, race, and age [AOR 0.74; 95% CI 0.58, 0.95; p < 0.05].
Conclusion: Urban areas are associated with lower rates of HTN medication adherence with increasing adherence in smaller communities. Additionally, Western US is correlated with a lower adherence rate compared to other regions. Further investigation into sources for this discrepancy is warranted, including potential differences in public health campaigns, prescribing practices, and follow up care. This knowledge could assist in the development of targeted solutions.
Information & Authors
Information
Published In
Copyright
© 2022 by American Heart Association, Inc.
History
Published in print: September 2022
Published online: 7 September 2022
Keywords
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
View Options
View options
PDF and All Supplements
Download PDF and All SupplementsLogin options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.